158 related articles for article (PubMed ID: 18565966)
21. The effect of In vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on Thrombelastograph.
Petroianu GA; Liu J; Maleck WH; Mattinger C; Bergler WF
Anesth Analg; 2000 Apr; 90(4):795-800. PubMed ID: 10735778
[TBL] [Abstract][Full Text] [Related]
22. A calcium-containing electrolyte-balanced hydroxyethyl starch (HES) solution is associated with higher factor VIII activity than is a non-balanced HES solution, but does not affect von Willebrand factor function or thromboelastometric measurements--results of a model of in vitro haemodilution.
Rau J; Rosenthal C; Langer E; Sander M; Schulte E; Schuster M; von Heymann C
Blood Transfus; 2014 Apr; 12(2):260-8. PubMed ID: 24333074
[TBL] [Abstract][Full Text] [Related]
23. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis.
Niemi TT; Kuitunen AH
Acta Anaesthesiol Scand; 2005 Mar; 49(3):373-8. PubMed ID: 15752404
[TBL] [Abstract][Full Text] [Related]
24. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation.
Boldt J; Haisch G; Suttner S; Kumle B; Schellhaass A
Br J Anaesth; 2002 Nov; 89(5):722-8. PubMed ID: 12393770
[TBL] [Abstract][Full Text] [Related]
25. Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit.
Le Saché F; Le Bonniec B; Gaussem P; Dizier B; Tagzirt M; Godier A; Emmerich J; Samama CM
Br J Anaesth; 2012 Apr; 108(4):586-93. PubMed ID: 22258204
[TBL] [Abstract][Full Text] [Related]
26. Effects of In vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood.
Darlington DN; Kremenevskiy I; Pusateri AE; Scherer MR; Fedyk CG; Kheirabaldi BS; Delgado AV; Dubick MA
Int J Burns Trauma; 2012; 2(1):42-50. PubMed ID: 22928166
[TBL] [Abstract][Full Text] [Related]
27. Differential clot stabilising effects of rFVIIa and rFXIII-A2 in whole blood from thrombocytopenic patients and healthy volunteers.
Johansson PI; Jacobsen N; Viuff D; Olsen EH; Rojkjaer R; Andersen S; Petersen LC; Kjalke M
Br J Haematol; 2008 Nov; 143(4):559-69. PubMed ID: 18950467
[TBL] [Abstract][Full Text] [Related]
28. [Thrombelastographic coagulation analysis following in vitro and in vivo haemodilution with hydroxyethyl starch (HES)].
Asskali F; Lehmann G; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 May; 37(5):258-66. PubMed ID: 12015682
[TBL] [Abstract][Full Text] [Related]
29. The effects of hydroxyethyl starch solutions on thromboelastography in preoperative male patients.
Felfernig M; Franz A; Bräunlich P; Fohringer C; Kozek-Langenecker SA
Acta Anaesthesiol Scand; 2003 Jan; 47(1):70-3. PubMed ID: 12492800
[TBL] [Abstract][Full Text] [Related]
30. An in vitro study comparing the effects of Hextend, Hespan, normal saline, and lactated ringer's solution on thrombelastography and the activated partial thromboplastin time.
Dailey SE; Dysart CB; Langan DR; Slye MJ; Nuttall GA; Schrader LM; Williams BA; Oliver WC
J Cardiothorac Vasc Anesth; 2005 Jun; 19(3):358-61. PubMed ID: 16130064
[TBL] [Abstract][Full Text] [Related]
31. Citrate artificially masks the haemostatic effect of recombinant factor VIIa in dilutional coagulopathy.
Fenger-Eriksen C; Ingerslev J; Tønnesen E; Sørensen B
Ann Hematol; 2009 Mar; 88(3):255-60. PubMed ID: 18696068
[TBL] [Abstract][Full Text] [Related]
32. [Effects of plasma substitutes on hemostasis].
Blanloeil Y; Trossaërt M; Rigal JC; Rozec B
Ann Fr Anesth Reanim; 2002 Oct; 21(8):648-67. PubMed ID: 12471786
[TBL] [Abstract][Full Text] [Related]
33. The effects of acidosis and hypothermia on blood transfusion requirements following factor VII administration.
Hall K; Forrest P; Sawyer C
Anaesth Intensive Care; 2007 Aug; 35(4):494-7. PubMed ID: 18020065
[TBL] [Abstract][Full Text] [Related]
34. Effects of increasing doses of activated recombinant factor VII on haemostatic parameters in swine.
Pusateri AE; Ryan KL; Delgado AV; Martinez RS; Uscilowicz JM; Cortez DS; Martinowitz U
Thromb Haemost; 2005 Feb; 93(2):275-83. PubMed ID: 15711743
[TBL] [Abstract][Full Text] [Related]
35. Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits.
Tranholm M; Rojkjaer R; Pyke C; Kristensen AT; Klitgaard B; Lollike K; Blajchman MA
Thromb Res; 2003 Feb; 109(4):217-23. PubMed ID: 12757777
[TBL] [Abstract][Full Text] [Related]
36. The effect of potato starch derived and corn starch derived hydroxyethyl starch on in vitro blood coagulation.
Jamnicki M; Zollinger A; Seifert B; Popovic D; Pasch T; Spahn DR
Anaesthesia; 1998 Jul; 53(7):638-44. PubMed ID: 9771171
[TBL] [Abstract][Full Text] [Related]
37. Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study.
Skolnick BE; Shenouda M; Khutoryansky NM; Pusateri AE; Gabriel D; Carr ME
Anesth Analg; 2011 Oct; 113(4):703-10. PubMed ID: 21890888
[TBL] [Abstract][Full Text] [Related]
38. Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study.
Godier A; Mazoyer E; Cymbalista F; Cupa M; Samama CM
J Thromb Haemost; 2007 Feb; 5(2):244-9. PubMed ID: 17129221
[TBL] [Abstract][Full Text] [Related]
39. Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.
Spronk HM; Braunschweig T; Rossaint R; Wüst DC; van Oerle R; Lauritzen B; Tolba R; Grottke O
PLoS One; 2015; 10(6):e0113979. PubMed ID: 26098426
[TBL] [Abstract][Full Text] [Related]
40. Ticagrelor reversal:
Calmette L; Martin AC; Le Bonniec B; Zlotnik D; Gouin-Thibault I; Bachelot-Loza C; Gaussem P; Godier A
J Clin Pathol; 2017 Sep; 70(9):733-739. PubMed ID: 28159767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
